Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | -2.74% | +2.90% | -86.94% |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 17 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 39.35M | Sales 2025 * | 58.17M | Capitalization | 78.01M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -77M | EV / Sales 2024 * | -1.26 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 54.53M | EV / Sales 2025 * | 0.4 x |
P/E ratio 2024 * |
-0.72
x | P/E ratio 2025 * |
-1.37
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -2.74% | ||
1 week | +2.90% | ||
1 month | +0.71% | ||
3 months | -85.05% | ||
6 months | -78.90% | ||
Current year | -86.94% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.42 | -2.74% | 866,191 |
24-05-30 | 1.46 | -5.19% | 1,091,992 |
24-05-29 | 1.54 | +2.67% | 1,599,892 |
24-05-28 | 1.5 | +8.70% | 1,963,520 |
24-05-24 | 1.38 | +6.15% | 1,147,466 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.94% | 78.01M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- MRNS Stock